Original contributionHydroxyethyl starch (HES) does not directly affect renal function in patients with no prior renal impairment☆
Introduction
The influence of colloid therapy such as hydroxyethyl starch (HES) on renal function remains largely unclear.1, 2, 3, 4 Possible disadvantages may include alteration in coagulation and organ function, but available studies are few and confined mostly to critically ill patients, whose renal functions were already impaired before the colloids were administered, and to histologic investigations. In a retrospective analysis of patients undergoing kidney transplantation who were treated with HES, kidney lesions with the characteristic of osmotic nephrosis were seen.3 These lesions, however, had no negative influence on graft function or serum creatinine three and six months after transplantation. In another study, acute renal failure was reported when patients with impaired renal function received very high molecular weight (Mw) HES (Mw 450,000 D, DS 0.7).5 Thus, HES preparations may, under certain circumstances, have detrimental consequences for renal function.
To date, there is little concrete evidence of renal dysfunction following HES therapy in low-risk patients. German case studies have reported increased creatinine levels as well as clinical kidney problems (such as pain in the renal area and swelling of the kidney parenchyma) in patients undergoing dilution therapy, but several control trials showed no evidence of renal dysfunction in terms of serum urea and creatinine changes.∗,†∗, † A disadvantage of all these studies is their use of markers that may have been too insensitive to detect initial or discrete changes in renal function. Only a few studies employed tests that could detect renal damage at a high level of sensitivity; for instance, those that measure the urinary excretion of kidney-specific enzymes and proteins.1, 2, 3, 4
In this controlled, randomized study, we investigated the possible influence of HES-solutions on the renal function in (otherwise healthy) subjects undergoing otological surgery. The effects of three different HES solution regimes (HES 200/0.5, 200/0.62, and 450/0.7) were compared with those of lactated Ringer’s solution (LRS). Renal function was assessed by measuring both commonly used parameters of renal function as well as changes in a number of specific hormones. Except for the fluid replacement volume used, the experimental conditions were identical in the four groups.
Section snippets
Subjects
The study included 60 ASA physical status I and II male patients who were scheduled to undergo middle ear surgery. Eligibility criteria were an expected operation time of more than three hours, the absence of hepatic or renal dysfunction, diabetes mellitus, and recent exposure to contrast media. Patients were prospectively randomized via sealed envelope assignment into four groups of 15 patients each to receive either lactated Ringer’s solution or different HES-solutions (Table 1). The study
Results
All patients were able to be discharged from the hospital between 10 and 14 days after surgery. There were no significant differences among the study groups concerning age, height, body weight, duration of anesthesia, or blood loss (Table 2). Neither were there differences in heart rate (HR) or electrolytes among the groups during the preoperative and postoperative periods (data not presented).
Urine excretion significantly increased in the group receiving LRS, an effect that lasted until the
Discussion
The results of this study are reassuring in that HES does not seem to impair renal function in ASA physical status I and II patients, even when renal damage has been assessed by the most sensitive markers available. In a different context, changes in urinary enzymes had been demonstrated only after a 24- to 48-hour delay after therapy.18, 19, 20 We therefore performed tests up to two days after surgery. For most parameters, either no difference among study groups and the control group, or no
References (27)
- et al.
Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients
Lancet
(1996) - et al.
Tamm-Horsfall protein-uromodulin (1950–1990)
Kidney Int
(1990) - et al.
The predictive value of enzymuria in cyclosporin A-induced renal toxicity in the rat
Toxicol Lett
(1986) - et al.
Renal aquaporins
Kidney Int
(1996) - et al.
Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation [Letter]
Lancet
(1993) - et al.
Catecholamine and renin-angiotensin response during controlled hypotension induced by prostaglandin E1 combined with hemodilution during isoflurane anesthesia
J Clin Anesth
(1997) - et al.
Atrial pressure and hormonal and renal responses to acute cardiac tamponade
Ann Thorac Surg
(1990) - et al.
Hydroxyethyl starch-induced transient renal failure in preexisting glomerular damage
Acta Med Aust
(1991) - et al.
Effect of hydroxyethyl starch solution on kidney function in surgical intensive care patients
Anasthesiol Intensivmed Notfallmed Schmerzther
(1997) - et al.
The influence of different intravascular volume replacement regimens on renal function in the elderly
Anesth Analg
(1999)
Elevated urinary specific gravity in acute oliguric renal failure due to hetastarch administration
N Y State J Med
Diltiazem potentiates angiotensin II-mediated renal prostacyclin synthesis
J Cardiovasc Pharmacol
Fully enzymatic inulin determination in small volume samples without deproteinization
Nephron
Cited by (55)
Colloids versus crystalloids in objective-guided fluid therapy, systematic review and meta-analysis. Too early or too late to draw conclusions
2015, Brazilian Journal of AnesthesiologyIncidence of postoperative death and acute kidney injury associated with i.v. 6% hydroxyethyl starch use: Systematic review and meta-analysis
2014, British Journal of AnaesthesiaCitation Excerpt :Four hundred and fifty-six non-duplicate citations were screened; of which, 34 studies underwent full scoring and data extraction. However, only 19 trials were suitable for inclusion in the meta-analysis, including a total of 1567 subjects.9 20–37 The characteristics of included studies are summarized in Table 1.
Safety profile of hydroxyethyl starches (HES): What's new
2010, Praticien en Anesthesie ReanimationHydroxyethyl starch interferes with human blood ex vivo coagulation, platelet function and sedimentation
2009, Acta Anaesthesiologica TaiwanicaHydroxyethyl starches: Different products - different effects
2009, AnesthesiologyA Critical Reassessment of the Kidney Risk Caused by Tetrastarch Products in the Perioperative and Intensive Care Environments
2023, Journal of Clinical Medicine
- ☆
Supported by the Else-Kröner-Fresenius Foundation, Bad Homburg, Germany.
- ∗
Staff Anesthesiologist
- †
Research Associate
- ‡
Professor of Anesthesiology and Chairman, Department of Anesthesiology and Intensive Care Medicine